Conjugated Linoleic Acid (CLA) Conference Presentations Perspectives on Conjugated Linoleic Acid Research, Current Status and Future Directions May 15-16, 2002 Lister Hill Auditorium Bethesda, MD Please note that you must have Adobe's free Acrobat Reader installed on your computer to view any of the files listed on this page. The Adobe Acrobat Reader runs on either Windows PC or Macintosh platforms, and can be downloaded here. Conference Presentations: The Origin of CLA Dale E. Bauman, Ph.D. Department of Animal Science, Division of Nutritional Sciences Cornell University Documentation of CLA Intake in Humans; What We Know and What We Should Know Shelley McGuire, Ph.D. Department of Food Science and Human Nutrition Washington State University Concepts for Development of an Anlytical Method to Determine CLA Composition in Food, Dietary Supplements, and Reference Materials Martin P. Yurawecz, B.A. U.S. Food and Drug Administration Conjugated Linoleic Acid Isomers and Mammary Lipid Metabolism Lance H. Baumgard, Ph.D. Department of Animal Sciences University of Arizona Panel Discussion: Potential Mechanisms for CLA-Mediated Alteration of Body Composition and Lipid Metabolism Harry J. Mersmann, Ph.D. USDA Agricultural Research Service Children's Nutrition Research Center Department of Pediatrics Baylor College of Medicine CLA and Mammary Cancer Prevention Research Clement Ip, Ph.D. Department of Experimental Pathology Roswell Park Cancer Institute Panel Discussion: Research Needs in CLA and Cancer Prevention Clement Ip, Ph.D. Department of Experimental Pathology Roswell Park Cancer Institute CLA in Experimental Atherosclerosis David Kritchevsky, Ph.D. The Wistar Institute Conjugated Linoleic Acid Reduces Fasting Glucose and is Inversely Correlated with Serum Leptin in Subjects with Type 2 Diabetes Mellitus Martha A. Belury, Ph.D., R.D. Department of Pathobiology University of Washington CLA and Bone Formation Bruce A. Watkins, Ph.D. Department of Food Science/Agriculture Purdue University Panel Discussion: Mechanisms of Conjugated Linoleic Acid in Health and Disease Josep Bassaganya-Riera, DVM, Ph.D. Veterinary Medical Research Institute Iowa State University Panel Discussion: CLA for Athlerosclerosis and Diabetes Therapy: Opportunities, State of the Field and Future Research Directions Karen L. Houseknecht, Ph.D. Department of Cardiovascular and Metabolic Diseases Pfizer Global Research and Development Seroprotection: CLA Stimulates Antigen Specific Antibody Production in Humans Marianne O'Shea, Ph.D. Department of Lipid Nutrition Loders Croklaan Panel Discussion: Human Trials / Efficacy Darshan S. Kelley, Ph.D. Western Human Nutrition Research Center Nutrition Department of the University of California ARS/USDA at the University of California, Davis